Chaize mixture alleviates NAFLD by regulating Glipr2-related autophagy/NLRP3 signaling
- 4 October 2025
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 166, 115600
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Beijing Municipality (7252209)
- National Natural Science Foundation of China (82004327)
This publication has 45 references indexed in Scilit:
- Mechanisms and therapeutic implications of selective autophagy in nonalcoholic fatty liver diseaseJournal of Advanced Research, 2024
- Gut-liver axis: Pathophysiological concepts and clinical implicationsCell Metabolism, 2022
- Hepatic Fibroblast Growth Factor 21 Is Involved in Mediating Functions of Liraglutide in Mice With Dietary ChallengeHepatology, 2021
- Integrative lipidomic and transcriptomic study unravels the therapeutic effects of saikosaponins A and D on non-alcoholic fatty liver diseaseActa Pharmaceutica Sinica B, 2021
- Hepatic autophagy fluctuates during the development of non-alcoholic fatty liver diseaseAnnals of Hepatology, 2020
- Xiaochaihu Decoction reduces hepatic steatosis and improves D-GalN/LPS-induced liver injury in hybrid grouper (Epinephelus lanceolatus♂ × Epinephelus fuscoguttatus♀)Fish & Shellfish Immunology, 2019
- Alisol A 24-acetate ameliorates nonalcoholic steatohepatitis by inhibiting oxidative stress and stimulating autophagy through the AMPK/mTOR pathwayChemico-Biological Interactions, 2018
- Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in miceHepatology, 2016
- Characterization of Gut Microbiomes in Nonalcoholic Steatohepatitis (NASH) Patients: A Connection Between Endogenous Alcohol and NASHHepatology, 2012
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005